|
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12e
| Section II. Neuropharmacology > |
Chapter 12. Adrenergic Agonists and Antagonists
Sections: Catecholamines and Sympathomimetic Drugs, Classification of Sympathomimetic Drugs, Endogenous Catecholamines,  Adrenergic Receptor Agonists,  1-Selective Adrenergic Receptor Agonists, 2-Selective Adrenergic Receptor Agonists, Miscellaneous Sympathomimetic Agonists, Other Sympathomimetic Agents, Therapeutic Uses of Sympathomimetic Drugs, Adrenergic Receptor Antagonists, Adrenergic Receptor Antagonists, 2 Adrenergic Receptor Antagonists, Additional Adrenergic Receptor Antagonists, Adrenergic Receptor Antagonists, Adverse Effects and Precautions, Therapeutic Uses, Clinical Use of Adrenergic Receptor Antagonists, Non-Selective Adrenergic Receptor Antagonists, 1 Selective Adrenergic Receptor Antagonists, Receptor Antagonists with Additional Cardiovascular Effects ("Third Generation" Blockers), Bibliography.
Topics Discussed: adrenergic alpha-agonists; adrenergic alpha-antagonists; chemistry of drugs affecting the adrenergic nervous system (adrenergic agents).
Excerpt:"Most of the actions of catecholamines and sympathomimetic agents can be classified into seven broad types:..."
The content above is only an excerpt.
For full access, log into an existing user account below,
purchase an annual subscription, or
purchase a short-term subscription to the complete website.
|
|
|
|
Or
|
|
|
|